APA (7th ed.) Citation

Taji, T., Kumamaru, H., Kataoka, Y., Iijima, K., Suwa, H., Ishiguro, H., . . . Saji, S. Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry. Elsevier.

Chicago Style (17th ed.) Citation

Taji, Tomoe, Hiraku Kumamaru, Yuki Kataoka, Kotaro Iijima, Hirofumi Suwa, Hiroshi Ishiguro, Naruto Taira, Takanori Ishida, and Shigehira Saji. Comparison of Neoadjuvant and Adjuvant Chemotherapy for Operable Triple-negative Breast Cancer Before the Era of Immune Checkpoint Inhibitors: A Retrospective Study from the Japanese National Clinical Database-Breast Cancer Registry. Elsevier.

MLA (9th ed.) Citation

Taji, Tomoe, et al. Comparison of Neoadjuvant and Adjuvant Chemotherapy for Operable Triple-negative Breast Cancer Before the Era of Immune Checkpoint Inhibitors: A Retrospective Study from the Japanese National Clinical Database-Breast Cancer Registry. Elsevier.